Medical guideline

首页肿瘤学指南检索结果

检索结果

按发表年份

共搜索到19条与epithelial有关的结果

The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：其他 | 腹膜肿瘤

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 输卵管癌

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
Ovarian Cancer(Guideline for Patients)

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：生殖 | 卵巢肿瘤

National Comprehensive Cancer Network

Patient Epithelial Ovarian Cancer treatment stage
指南简介 原文链接
The 2020 Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Japan Society of Gynecologic Oncology

The Fifth Edition of the Japan Society of Gynecologic Oncology Guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer Was Published in 2020. the Guidelines Contain 6 Chapters-namely (1) Overview of the Guidelines (2) Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (4) Borderline Epithelial Tumors of the Ovary (5) Malignant Germ Cell Tumors of the Ovary and (6) Malignant Sex Cord-stromal Tumors. Furthermore the Guidelines Comprise 5 Algorithms-namely (1) Initial Treatment for Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (2) Treatment for Recurrent Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer (3) Initial Treatment for Borderline Epithelial Ovarian Tumor (4) Treatment for Malignant Germ Cell Tumor and (5) Treatment for Sex Cord-stromal Tumor. Major Changes in the New Edition Include the Following: (1) Revision of the Title to "guidelines for the Treatment of Ovarian Cancer Fallopian Tube Cancer and Primary Peritoneal Cancer" (2) Involvement of Patients and General (male/female) Participants in Addition to Physicians Pharmacists and Nurses (3) Clinical Questions (CQs) in the PICO Format (4) Change in the Expression of Grades of Recommendation and Level of Evidence in Accordance with the GRADE System (5) Introduction of the Idea of a Body of Evidence (6) Categorization of References According to Research Design (7) Performance of Systematic Reviews and Meta-analysis for Three CQs and (8) Voting for Each CQ/recommendation and Description of the Consensus.
指南简介 原文链接
An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation Or Maintenance Systemic Therapy for Newly Diagnosed Stage Ii, Iii, Or Iv Epithelial Ovary, Fallopian Tube, Or Primary Peritoneal Carcinoma

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

Objective: to Provide Recommendations on Systemic Therapy Options in Consolidation Or Maintenance Therapy for Women with Newly Diagnosed Stage II III Or IV Epithelial Ovary Fallopian Tube Or Primary Peritoneal Carcinoma Including All Histological Types. Methods: Consistent with the Program in Evidence-based Program's Standardized Approach MEDLINE EMBASE PubMed Cochrane Library and PROSPERO (the International Prospective Register of Systematic Reviews) Databases and Four Relevant Conferences Were Systematically Searched. the Working Group Drafted Recommendations and Revised Them Based on the Comments from Internal and External Reviewers. Results: We Have One Recommendation for Consolidation Therapy and Eight Recommendations for Maintenance Therapy. Overall Consolidation Therapy with Chemotherapy Should Not Be Recommended in the Target Population. for Maintenance Therapy We Recommended Olaparib (Recommendation) Niraparib (Weak Recommendation) Veliparib (Weak Recommendation) and Bevacizumab (Weak Recommendation) for Certain Patients with Newly Diagnosed Stage III-IV Epithelial Ovarian Fallopian Tube Or Primary Peritoneal Carcinoma Respectively. We Do Not Recommend Some Agents as Maintenance Therapy in Four Recommendations. We Are Unable to Specify the Patient Population by Histological Types for Different Maintenance Therapy Recommendations. When New Evidence That Can Impact the Recommendations Is Available the Recommendations Will Be Updated as Soon as Possible.
指南简介 原文链接
The S2k Guidelines on Vaginal Cancer

2020年发布于 Gynakologe 53卷第10期 所属人体系统：生殖 | 阴道肿瘤

Committee on the Vulva and Vagina of the Working Group for Gynecological Oncology

Sentinel Lymph Nodes Vaginal Neoplasms Laser Treatment Vaginal Squamous Cell Carcinoma Squamous Intraepithelial Lesions
指南简介 原文链接
British Gynaecological Cancer Society (BGCS) Vulval Cancer Guidelines: Recommendations for Practice

2020年发布于 European Journal of Obstetrics & Gynecology and Reproductive Biology 252卷第期 所属人体系统：生殖 | 外阴癌

British Gynaecological Cancer Society

Chemotherapy Lichen Sclerosis Radiotherapy Surgery Vulval Cancer Vulvar Intraepithelial Neoplasia.
指南简介 原文链接
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline

2020年发布于 American Society of Clinical Oncology 卷第期 所属人体系统：生殖 | 卵巢肿瘤

American Society of Clinical Oncology

Ovarian Cancer genetic Testing tumor Testing epithelial expert Consensus
指南简介 原文链接
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

2020年发布于 American Society of Clinical Oncology 卷第期 所属人体系统：生殖 | 卵巢肿瘤

American Society of Clinical Oncology

Ovarian Cancer PARP Inhibitors Management treatment epithelial Ovarian Tubal Or Primary Peritoneal Cancer (EOC)
指南简介 原文链接
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline Summary

2020年发布于 JCO Oncology Practice 16卷第8期 所属人体系统：生殖 | 卵巢肿瘤

American Society of Clinical Oncology

Epithelial Ovarian Cancer Germline Somatic Tumor Testing Guideline
指南简介 原文链接
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms

2020年发布于 Cancer 126卷第11期 所属人体系统：生殖 | 卵巢肿瘤

Chicago Consensus Working Group

Consensus Neoplasm Metastasis Ovarian Epithelial Neoplasm Ovarian Neoplasms Peritoneal Neoplasms.
指南简介 原文链接
Human Papillomavirus Vaccination: the ESGO-EFC Position Paper of the European Society of Gynaecologic Oncology and the European Federation for Colposcopy

2019年发布于 Eur J Cancer 116卷第_期 所属人体系统：生殖 | 子宫肿瘤

European Society of Gynaecologic Oncology European Federation for Colposcopy

CIN Cervical Cancer Cervical Intraepithelial Neoplasia HPV Immunity Prevention Vaccination.
指南简介 原文链接
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up

2019年发布于 Geburtshilfe Frauenheilkd 79卷第2期 所属人体系统：生殖 | 子宫肿瘤

German Society of Gynecology and Obstetrics German Society for Epidemiology German Society for Virology German Society of Pathology German STI Society German Society for Cytology German Society for Medical Informatics Biometry and Epidemiology Gynecological Oncology Working Group of the DKG Self-help for Women after Cancer Professional Association of Gynecologists Federal Association of Senior Physicians in Gynecology and Obstetrics Professional Association of German Physicians Working in Cytology Cervical Pathology and Colposcopy Working Group of the DGGG Prevention and Integrative Oncology Working Group of the DKG Section B HPV Management Forum of the Paul Ehrlich Society for Chemotherapy Colposcopy Study Group Working Group on Infections and Immunology of the DGGG German Cancer Research Center Gynecological Oncology and Breast Health Working Group of the SGGG Gynecological Oncology of the OEGGG European Society of Gynaecological Oncology

HPV Cervical Cancer Cervical Intraepithelial Neoplasia (CIN) Cervical Precancerous Condition.
指南简介 原文链接
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia

2019年发布于 Geburtshilfe Frauenheilkd 79卷第2期 所属人体系统：生殖 | 子宫肿瘤

German Society of Gynecology and Obstetrics German Society for Epidemiology German Society for Virology German Society of Pathology German STI Society German Society for Cytology German Society for Medical Informatics Biometry and Epidemiology Gynecological Oncology Working Group of the DKG Self-help for Women after Cancer Professional Association of Gynecologists Federal Association of Senior Physicians in Gynecology and Obstetrics Professional Association of German Physicians Working in Cytology Cervical Pathology and Colposcopy Working Group of the DGGG Prevention and Integrative Oncology Working Group of the DKG Section B HPV Management Forum of the Paul Ehrlich Society for Chemotherapy Colposcopy Study Group Working Group on Infections and Immunology of the DGGG German Cancer Research Center Gynecological Oncology and Breast Health Working Group of the SGGG Gynecological Oncology of the OEGGG European Society of Gynaecological Oncology

HPV Cervical Cancer Cervical Intraepithelial Neoplasia (CIN) Cervical Precancerous Condition
指南简介 原文链接
Diagnostic and Treatment Pitfalls and Guidelines for Variants of Squamous Cell Carcinomas of the Head and Neck: on Behalf of the REFCOR

2019年发布于 Bull Cancer 106卷第4期 所属人体系统：其他 | 头颈部肿瘤

Réseau D'expertise Franais Sur Les Cancers ORL Rares

Acantholytic Acantholytique/adénoïde Adenoid Carcinoma Adenosquamous Adénosquameux Basaloid Basaloïde Cancer/carcinome HNSCC Head and Neck Cancer Lymphoepithelial Lymphoépithélial Papillaire Papillary Sarcomatoid Spindle Cell Squamous Cell Carcinoma Variant Verrucous Verruqueux Voies Aérodigestives Supérieures À Cellules Fusiformes/sarcomatoïde Épidermoïde.
指南简介 原文链接
Surgery in Ovarian Cancer - Brazilian Society of Surgical Oncology Consensus

2018年发布于 BJOG 125卷第10期 所属人体系统：生殖 | 卵巢肿瘤

Brazilian Society of Surgical Oncology

Brazilian Society of Surgical Oncology Consensus Epithelial Ovarian Cancer Surgery
指南简介 原文链接
A Statement by the Japan-Korea Expert Pathologists for Future Clinicopathological and Molecular Analyses Toward Consensus Building of Intraductal Papillary Neoplasm of the Bile Duct Through Several Opinions at the Present Stage

2018年发布于 J Hepatobiliary Pancreat Sci 25卷第3期 所属人体系统：消化 | 胆管肿瘤

无

Intraductal Papillary Neoplasm of Bile Duct Biliary Intraepithelial Neoplasia Cholangiocarcinoma Papillary Cholangiocarcinoma
指南简介 原文链接

人体系统

共搜索到19条 与epithelial有关的结果

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 其他 | 腹膜肿瘤

Ontario Health (Cancer Care Ontario)

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 生殖 | 输卵管癌

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 输卵管癌

Ontario Health (Cancer Care Ontario)

2021年 发布于 National Comprehensive Cancer Network 卷 第期 所属人体系统： 生殖 | 卵巢肿瘤

National Comprehensive Cancer Network

2021年 发布于 Journal of Gynecologic Oncology 32卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Japan Society of Gynecologic Oncology

2021年 发布于 Current Oncology 28卷 第2期 所属人体系统： 生殖 | 卵巢肿瘤

Ontario Health (Cancer Care Ontario)

2020年 发布于 Gynakologe 53卷 第10期 所属人体系统： 生殖 | 阴道肿瘤

Committee on the Vulva and Vagina of the Working Group for Gynecological Oncology

2020年 发布于 European Journal of Obstetrics & Gynecology and Reproductive Biology 252卷 第期 所属人体系统： 生殖 | 外阴癌

British Gynaecological Cancer Society

2020年 发布于 American Society of Clinical Oncology 卷 第期 所属人体系统： 生殖 | 卵巢肿瘤

American Society of Clinical Oncology

2020年 发布于 American Society of Clinical Oncology 卷 第期 所属人体系统： 生殖 | 卵巢肿瘤

American Society of Clinical Oncology

2020年 发布于 JCO Oncology Practice 16卷 第8期 所属人体系统： 生殖 | 卵巢肿瘤

American Society of Clinical Oncology

2020年 发布于 Cancer 126卷 第11期 所属人体系统： 生殖 | 卵巢肿瘤

Chicago Consensus Working Group

2019年 发布于 Eur J Cancer 116卷 第_期 所属人体系统： 生殖 | 子宫肿瘤

European Society of Gynaecologic Oncology European Federation for Colposcopy

2019年 发布于 Geburtshilfe Frauenheilkd 79卷 第2期 所属人体系统： 生殖 | 子宫肿瘤

2019年 发布于 Geburtshilfe Frauenheilkd 79卷 第2期 所属人体系统： 生殖 | 子宫肿瘤

2019年 发布于 Bull Cancer 106卷 第4期 所属人体系统： 其他 | 头颈部肿瘤

Réseau D'expertise Franais Sur Les Cancers ORL Rares

2018年 发布于 BJOG 125卷 第10期 所属人体系统： 生殖 | 卵巢肿瘤

Brazilian Society of Surgical Oncology

2018年 发布于 J Hepatobiliary Pancreat Sci 25卷 第3期 所属人体系统： 消化 | 胆管肿瘤

无

共搜索到19条与epithelial有关的结果

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：其他 | 腹膜肿瘤

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 输卵管癌

2021年发布于 National Comprehensive Cancer Network 卷第期 所属人体系统：生殖 | 卵巢肿瘤

2021年发布于 Journal of Gynecologic Oncology 32卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2021年发布于 Current Oncology 28卷第2期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 Gynakologe 53卷第10期 所属人体系统：生殖 | 阴道肿瘤

2020年发布于 European Journal of Obstetrics & Gynecology and Reproductive Biology 252卷第期 所属人体系统：生殖 | 外阴癌

2020年发布于 American Society of Clinical Oncology 卷第期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 American Society of Clinical Oncology 卷第期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 JCO Oncology Practice 16卷第8期 所属人体系统：生殖 | 卵巢肿瘤

2020年发布于 Cancer 126卷第11期 所属人体系统：生殖 | 卵巢肿瘤

2019年发布于 Eur J Cancer 116卷第_期 所属人体系统：生殖 | 子宫肿瘤

2019年发布于 Geburtshilfe Frauenheilkd 79卷第2期 所属人体系统：生殖 | 子宫肿瘤

2019年发布于 Geburtshilfe Frauenheilkd 79卷第2期 所属人体系统：生殖 | 子宫肿瘤

2019年发布于 Bull Cancer 106卷第4期 所属人体系统：其他 | 头颈部肿瘤

2018年发布于 BJOG 125卷第10期 所属人体系统：生殖 | 卵巢肿瘤

2018年发布于 J Hepatobiliary Pancreat Sci 25卷第3期 所属人体系统：消化 | 胆管肿瘤